• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Verastem, Inc. - Common Stock (NQ:VSTM)

    10.60 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EST, Dec 4, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Verastem, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 8 9 10 Next >
    News headline image
    Verastem Oncology Announces Pricing of $85.0 Million Public Offering of Common Stock and Pre-Funded Warrants
    From Verastem Oncology
    Via Business Wire
    News headline image
    Verastem Oncology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
    From Verastem Oncology
    Via Business Wire
    News headline image
    Crude Oil Rises Sharply; Jabil Posts Upbeat Q3 Results ↗
    U.S. stocks traded higher toward the end of trading, with Dow Jones gaining around 450 points on Thursday. The Dow traded up 1.32% to 34,429.39 while the NASDAQ rose 1.27% to 13,799.28. The S&P 500,... 
    Via Benzinga
    News headline image
    Verastem Stock Is Outperforming 92% Of The Market — And It Just Surged ↗
    The company is testing a treatment for a form of ovarian cancer. 
    Via Investor's Business Daily
    News headline image
    Verastem: Q1 Earnings Insights ↗
     
    Via Benzinga
    News headline image
    Analyst Initiates Verastem With Neutral While 'Waiting For FDA Go-Ahead' ↗
     
    Via Benzinga
    News headline image
    Verastem's Ovarian Cancer Drug Showing Promise, Analyst Upgrades Stock ↗
    Mizuho Securities has upgraded Verastem Inc (NASDAQ: VSTM) from Neutral to Buy with a price target of $36, up from $24, to  
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Thursday's Intraday Session ↗
     
    Via Benzinga
    News headline image
    Benzinga's Top Ratings Upgrades, Downgrades For June 15, 2023 ↗
     
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    Verastem To Rally Around 287%? Here Are 10 Other Analyst Forecasts For Thursday ↗
    Piper Sandler boosted the price target for Accenture plc (NYSE: ACN) from $250 to $316. Piper Sandler analyst Arvind Ramnani upgraded the stock from Underweight to Neutral. Accenture shares rose 1.1%... 
    Via Benzinga
    Traders Insights: These Biotech Stocks On Radar: VSTM, SNTX, CGEN, SONN
    Via AB Newswire
    News headline image
    AI Boom Wanes In June: Nvidia Falls Under $1T As Benzinga Reviews May's Champions ↗
     
    Via Benzinga
    Neurofibromatosis Treatment Market Value Expected to Reach $27 Billion By End Of 2029
    EQNX::TICKER_START (NASDAQ:KTTA),(NASDAQ:SWTX),(NASDAQ:DAWN),(NASDAQ:VSTM),(NASDAQ:KNTE) EQNX::TICKER_END 
    Via FinancialNewsMedia
    News headline image
    Verastem Oncology Announces Reverse Stock Split
    From Verastem Oncology
    Via Business Wire
    News headline image
    12 Health Care Stocks Moving In Monday's Intraday Session ↗
     
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Friday's Intraday Session ↗
     
    Via Benzinga
    News headline image
    Updated Data from Part A of Verastem Oncology's RAMP 201 Trial Show an Objective Response Rate of 45% in Patients with Recurrent Low-Grade Serous Ovarian Cancer Treated with Avutometinib and Defactinib
    From Verastem Oncology
    Via Business Wire
    News headline image
    Why Hibbett Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
    Gainers Onfolio Holdings, Inc. (NASDAQ: ONFO) gained 73% to $2.02 after the company announced it completed development of a generative AI search tool. 
    Via Benzinga
    News headline image
    Verastem Oncology Appoints Karin Tollefson, PhD, to Board of Directors
    From Verastem Oncology
    Via Business Wire
    News headline image
    Verastem Oncology Reports First Quarter 2023 Financial Results and Highlights Recent Company Progress
    From Verastem Oncology
    Via Business Wire
    News headline image
    Verastem Oncology to Participate in Upcoming Investor Conferences
    From Verastem Oncology
    Via Business Wire
    News headline image
    New Data from Interim Analysis of Verastem Oncology’s RAMP 201 Trial Evaluating Avutometinib and Defactinib in Recurrent Low-Grade Serous Ovarian Cancer to be Presented at the American Society of Clinical Oncology Annual Meeting
    From Verastem Oncology
    Via Business Wire
    News headline image
    Verastem Oncology to Present at the Stifel 2023 Virtual Targeted Oncology Days
    From Verastem Oncology
    Via Business Wire
    News headline image
    7 Very Undervalued Penny Stocks to Buy in April 2023 ↗
    Undervalued penny stocks present investors who are very bullish on the near-term future with a high-risk, high-reward option. 
    Via InvestorPlace
    News headline image
    Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Verastem Oncology
    Via Business Wire
    News headline image
    Benzinga's Top Ratings Upgrades, Downgrades For March 30, 2023 ↗
     
    Via Benzinga
    News headline image
    New Verastem Oncology Initiative, Let’s Talk About LGSOC, Calls Attention to Rare Form of Ovarian Cancer
    From Verastem Oncology
    Via Business Wire
    News headline image
    Verastem Oncology Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Recent Company Progress
    From Verastem Oncology
    Via Business Wire
    News headline image
    12 Health Care Stocks Moving In Monday's After-Market Session ↗
     
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 8 9 10 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.